Organogenesis Holdings Inc
NASDAQ:ORGO

Watchlist Manager
Organogenesis Holdings Inc Logo
Organogenesis Holdings Inc
NASDAQ:ORGO
Watchlist
Price: 3.755 USD -15.24%
Market Cap: 497.8m USD
Have any thoughts about
Organogenesis Holdings Inc?
Write Note

Intrinsic Value

The intrinsic value of one ORGO stock under the Base Case scenario is 3.294 USD. Compared to the current market price of 3.755 USD, Organogenesis Holdings Inc is Overvalued by 12%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ORGO Intrinsic Value
3.294 USD
Overvaluation 12%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Organogenesis Holdings Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ORGO cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ORGO?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Biotechnology Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Organogenesis Holdings Inc

Provide an overview of the primary business activities
of Organogenesis Holdings Inc.

What unique competitive advantages
does Organogenesis Holdings Inc hold over its rivals?

What risks and challenges
does Organogenesis Holdings Inc face in the near future?

Has there been any significant insider trading activity
in Organogenesis Holdings Inc recently?

Summarize the latest earnings call
of Organogenesis Holdings Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Organogenesis Holdings Inc.

Provide P/S
for Organogenesis Holdings Inc.

Provide P/E
for Organogenesis Holdings Inc.

Provide P/OCF
for Organogenesis Holdings Inc.

Provide P/FCFE
for Organogenesis Holdings Inc.

Provide P/B
for Organogenesis Holdings Inc.

Provide EV/S
for Organogenesis Holdings Inc.

Provide EV/GP
for Organogenesis Holdings Inc.

Provide EV/EBITDA
for Organogenesis Holdings Inc.

Provide EV/EBIT
for Organogenesis Holdings Inc.

Provide EV/OCF
for Organogenesis Holdings Inc.

Provide EV/FCFF
for Organogenesis Holdings Inc.

Provide EV/IC
for Organogenesis Holdings Inc.

Show me price targets
for Organogenesis Holdings Inc made by professional analysts.

What are the Revenue projections
for Organogenesis Holdings Inc?

How accurate were the past Revenue estimates
for Organogenesis Holdings Inc?

What are the Net Income projections
for Organogenesis Holdings Inc?

How accurate were the past Net Income estimates
for Organogenesis Holdings Inc?

What are the EPS projections
for Organogenesis Holdings Inc?

How accurate were the past EPS estimates
for Organogenesis Holdings Inc?

What are the EBIT projections
for Organogenesis Holdings Inc?

How accurate were the past EBIT estimates
for Organogenesis Holdings Inc?

Compare the revenue forecasts
for Organogenesis Holdings Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Organogenesis Holdings Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Organogenesis Holdings Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Organogenesis Holdings Inc compared to its peers.

Compare the P/E ratios
of Organogenesis Holdings Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Organogenesis Holdings Inc with its peers.

Analyze the financial leverage
of Organogenesis Holdings Inc compared to its main competitors.

Show all profitability ratios
for Organogenesis Holdings Inc.

Provide ROE
for Organogenesis Holdings Inc.

Provide ROA
for Organogenesis Holdings Inc.

Provide ROIC
for Organogenesis Holdings Inc.

Provide ROCE
for Organogenesis Holdings Inc.

Provide Gross Margin
for Organogenesis Holdings Inc.

Provide Operating Margin
for Organogenesis Holdings Inc.

Provide Net Margin
for Organogenesis Holdings Inc.

Provide FCF Margin
for Organogenesis Holdings Inc.

Show all solvency ratios
for Organogenesis Holdings Inc.

Provide D/E Ratio
for Organogenesis Holdings Inc.

Provide D/A Ratio
for Organogenesis Holdings Inc.

Provide Interest Coverage Ratio
for Organogenesis Holdings Inc.

Provide Altman Z-Score Ratio
for Organogenesis Holdings Inc.

Provide Quick Ratio
for Organogenesis Holdings Inc.

Provide Current Ratio
for Organogenesis Holdings Inc.

Provide Cash Ratio
for Organogenesis Holdings Inc.

What is the historical Revenue growth
over the last 5 years for Organogenesis Holdings Inc?

What is the historical Net Income growth
over the last 5 years for Organogenesis Holdings Inc?

What is the current Free Cash Flow
of Organogenesis Holdings Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Organogenesis Holdings Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Organogenesis Holdings Inc

Current Assets 234.2m
Cash & Short-Term Investments 89.9m
Receivables 105.9m
Other Current Assets 38.3m
Non-Current Assets 209m
PP&E 126.5m
Intangibles 42.9m
Other Non-Current Assets 39.5m
Current Liabilities 85.7m
Accounts Payable 29.4m
Accrued Liabilities 39m
Other Current Liabilities 17.3m
Non-Current Liabilities 93.9m
Long-Term Debt 59m
Other Non-Current Liabilities 34.9m
Efficiency

Earnings Waterfall
Organogenesis Holdings Inc

Revenue
448.4m USD
Cost of Revenue
-111.5m USD
Gross Profit
336.9m USD
Operating Expenses
-324.9m USD
Operating Income
12m USD
Other Expenses
-28.5m USD
Net Income
-16.5m USD

Free Cash Flow Analysis
Organogenesis Holdings Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ORGO Profitability Score
Profitability Due Diligence

Organogenesis Holdings Inc's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROE
Positive 3-Year Average ROIC
Positive Revenue Growth Forecast
51/100
Profitability
Score

Organogenesis Holdings Inc's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

ORGO Solvency Score
Solvency Due Diligence

Organogenesis Holdings Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
53/100
Solvency
Score

Organogenesis Holdings Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ORGO Price Targets Summary
Organogenesis Holdings Inc

Wall Street analysts forecast ORGO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ORGO is 4.463 USD with a low forecast of 3.03 USD and a high forecast of 6.3 USD.

Lowest
Price Target
3.03 USD
19% Downside
Average
Price Target
4.463 USD
19% Upside
Highest
Price Target
6.3 USD
68% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ORGO?

Click here to dive deeper.

Dividends

Organogenesis Holdings Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ORGO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ORGO Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Organogenesis Holdings Inc Logo
Organogenesis Holdings Inc

Country

United States of America

Industry

Biotechnology

Market Cap

499.1m USD

Dividend Yield

0%

Description

Organogenesis Holdings, Inc. is a regenerative medical company. The company is headquartered in Canton, Massachusetts and currently employs 950 full-time employees. The company went IPO on 2016-12-02. Its solutions address comorbidities such as diabetes, obesity, cardiovascular and peripheral vascular disease, and smoking. The wound care products include Apligraf for the treatment of venous leg ulcers (VLUs) and diabetic foot ulcers (DFUs); Dermagraft for the treatment of diabetic foot ulcer (DFU); PuraPly AM and PuraPly XT as antimicrobial barriers for variety of wound types; and the Affinity and NuShield wound coverings to address a variety of wound sizes and types. Its surgical and sports medicine product includes ReNu for in-office knee osteoarthritis treatment; NuCel for bony fusion in the lumbar spine; NuShield and Affinity barrier products for surgical application in targeted soft tissue repairs; and PuraPly AM for management of open wounds in the surgical setting.

Contact

MASSACHUSETTS
Canton
85 Dan Rd
+17815750775.0
investors.organogenesis.com

IPO

2016-12-02

Employees

950

Officers

President, CEO, Chair of the Board
Mr. Gary S. Gillheeney Sr.
Chief Financial Officer
Mr. David C. Francisco
Chief Operating Officer
Mr. Patrick Bilbo
Chief Administrative & Legal Officer
Ms. Lori H. Freedman B.A., Esq., J.D.
Chief Commercial Officer
Mr. Brian Grow
Secretary
Mr. William R. Kolb CPA
Show More
Vice President of Strategy
Mr. Robert Cavorsi
Show Less

See Also

Discover More
What is the Intrinsic Value of one ORGO stock?

The intrinsic value of one ORGO stock under the Base Case scenario is 3.294 USD.

Is ORGO stock undervalued or overvalued?

Compared to the current market price of 3.755 USD, Organogenesis Holdings Inc is Overvalued by 12%.

Back to Top